Viewing Study NCT03478605


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2025-12-26 @ 2:11 AM
Study NCT ID: NCT03478605
Status: UNKNOWN
Last Update Posted: 2018-07-05
First Post: 2018-03-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis
Sponsor: Blokhin's Russian Cancer Research Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module